National Prescribing Service (Australia)
Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for cardiovascular outcomes with sodium glucose cotransporter 2 inhibitors in the real world)
MOTS-C is a mitochondrial-derived peptide that enhances metabolic function, improves insulin sensitivity, and supports cellular energy production
Hence, an interesting question that remains unaddressed is whether inhibitors of necroptosis molecules attenuate CP-induced AKI by controlling lysosomal biogenesis and autophagic flux through TFEB
You should also contact your medical provider if symptoms are severe, do not improve, or are accompanied by vomiting, diarrhea, fainting, confusion, severe abdominal pain, or an inability to keep fluids down